# Thiopurine Induced Pancreatitis in IBD Patients

> **NCT02281799** · PHASE4 · WITHDRAWN · sponsor: **Shaare Zedek Medical Center**

## Conditions studied

- Pancreatitis
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Azathioprine

## Key facts

- **NCT ID:** NCT02281799
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No Participants Enrolled
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02281799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02281799, "Thiopurine Induced Pancreatitis in IBD Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02281799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*